abstract |
An effective influenza vaccine is provided via an intradermal route. The present invention relates to the use of a trivalent non-live influenza antigen preparation, particularly an influenza virus component preparation, in the manufacture of a single volume influenza vaccine for intradermal delivery. [Selection figure] None |